Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2005-09-06
2005-09-06
Minnifield, Nita (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S266100, C424S184100, C424S191100, C424S093100
Reexamination Certificate
active
06939549
ABSTRACT:
Vaccines and methods useful to induce an immune response which is protective to reduce the severity or prevent infection by ehrlichial parasites of the speciesAnaplasma marginaleutilizing recombinant MSP1a surface protein antigens alone or in combination with tick cell culture derivedA. marginale.
REFERENCES:
patent: 3674860 (1972-07-01), Welter et al.
patent: 4956278 (1990-09-01), Hart et al.
patent: 5549898 (1996-08-01), McGuire et al.
patent: 5798219 (1998-08-01), Knowles et al.
patent: 5869335 (1999-02-01), Munderloh et al.
patent: 6025338 (2000-02-01), Barbet et al.
patent: 6242571 (2001-06-01), Knowles et al.
patent: 2002/0127242 (2002-09-01), de la Fuente et al.
patent: 196290 (1986-10-01), None
patent: WO 97/08296 (1997-03-01), None
patent: WO 03/093416 (2003-11-01), None
Garcia-Garcia et al, Vet. Immunology and Immunopathology, 2004, 98:137-151.
de la Fuente et al, J. Applied Research in Vet. Med., 2003, 1/4:285-292.
Blouin et al, Vet. Parasitology, Feb. 2003, 111/2-3:247-260.
de la Fuente et al, Vet. Microbiology, Oct. 2002, 89/2-3:239-251.
Kocan et al, Experimental and Applied Acaralogy, 2002, 28/1-4:9-25.
Camacho-Nuez et al Infection & Immunity 68/4: 1946-1952, Apr. 2000.
Brown et al, Infection & Immunity 66/11: 5414-5422, Nov. 1998.
Palmer et al Infection & Immunity 50/3: 881-886, Dec. 1985.
Arulkanthan et al, Infection & Immunity 67/7: 3481-3487, Jul. 1999.
McGuire etal, Vaccine, 12/5: 465-471, 1994.
Bowie etal, Gene, 282: 95-102, 2002.
Brown etal, Infection & Immunity 69/11: 6853-6862, Nov. 2001.
de la Fuente etal, International J Parasitology 31: 1705-1714, 2001.
Palmer et al, Parasitology Today 15/7: 281-286, 1999.
Vidotto et al, Infection and Immunity, 62/7: 2940-2946, Jul. 1994.
McGarey DJ, Barbet AF, Palmer GH, McGuire TC, Allred Dr. Putative adhesins ofAnaplasma marginale: major surface polypeptides 1a and 1b. Infect Immun 1994; 62: 4594-4601.
Munderloh UG, Blouin EF, Kocan KM, Ge NL. Establishment of the tick (Acari: Ixodidae)-borne cattle pathogenAnaplasma marginale(Rickettsiales:Anaplasmataceae) in tick cell culture. J Med Ent 1996; 33: 656-664.
Oberle SM, Palmer GH, Barbet AF, McGuire TC. Molecular size variations in an immunoprotective protein complex among isolates ofAnaplasma marginale. Infect Immun 1988; 56: 1567-1573.
Palmer GH, Barbet AF, Cantor GH, McGuire TC. Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variantAnaplasma marginaleisolate. Infect Immun 1989; 57: 3666-3669.
Palmer GH, McElwain TF. “Molecular basis for vaccine development againstanaplasmosisand babesiosis.” Vet Parasitol: 1995; 57: 233-253.
Palmer GH, Waghela SD, Barbet AF, Davis WC, McGuire TC. Characterization of a neutralization-sensitive epitope on the AM 105 surface protein ofAnaplasma marginale. J Parasitol 1987: 17: 1279-1285.
Viseshakul N, Kamper S, Bowie MV, Barbet AF. Sequence and expression analysis of a surface antigen gene family of the rickettsiaAnaplasma marginale. Gene 2000; 253: 45-53.
Allred DR, McGuire TC, Palmer GH, Leib SR, Harkins TM, McElwain TF, Barbet AF. Molecular basis for surface antigen size polymorphisms and conservation of a neutralization-sensitive epitope inAnaplasma marginale. Proc Natl Acad Sci USA 1990; 87: 3220-3224.
Barbet AF, Blentlinger R, Jooyoung Y, Lundgren AM, Blouin EF, Kocan KM. Comparison of surface proteins ofAnaplasma marginalegrown in tick cell culture, tick salivary glands, and cattle. Infect Immun 1999; 67: 102-107.
Barbet AF, Palmer GH, Myler PJ, McGuire TC. Characterization of an immunoprotective protein complex ofAnaplasma marginaleby cloning and expression of the gene coding for polypeptide AM 105L. Infect Immun1987; 55: 2428-2435.
Blouin EF, Barbet AF, Jooyoung Y, Kocan KM, Saliki JT. Establishment and characterization of an Oklahoma isolate ofAnaplasma marginalein culturedIxodes scapulariscells. Vet Parasitol 1999; 87: 301-313.
Blouin EF, Kocan KM. Morphology and development ofAnaplasma marginale(Rickettsiales: Anaplasmataceae) in culturedIxodes scapularis(Acari:Ixodidae) cells. J Med Entomol 1998; 35: 788-797.
De la Fuente J, Garcia-Garcia JC, Blouin EF, Kocan KM. Differential adhesion of major surface proteins 1a and 1b of the ehrlichial cattle pathogenAnaplasma marginaleto bovine erythrocytes and tick cells. Int. J. Parasitol. 2001; 31: 145-153.
De la Fuente J, Van Den Bussche RA, Kocan KM. Molecular phylogeny and biogeography of North American isolates ofAnaplasma marginale(Rickettsiaceae: Ehrlichieae). Vet Parasitol 2001; 97: 65-76.
Kocan KM, Blouin EF, Barbet AF. Anaplasmosis control: past, present and future. Ann NY Acad Sci, 2000; 916: 501-509.
McGarey DJ, Allred DR. Characterization of hemagglutinating components on theAnaplasma marginaleinitial body surface and identification of possible adhesins. Infect Immun 1994; 62: 4587-4593.
PCT International Search Report. PCT/US01/48505. p. 1-5.
Arulkanthan, Appudurai, et al. Biased Immunoglobulin G1 Isotype Responses Induced in Cattle with DNA Expresing msp 1a ofAnaplasma marginale. Infection and Immunity, Jul. 1999, p. 3481-3487.
Almazan et al., 2003Vaccine21:1492-1501.
Blouin et al., Antibodies toAnaplasma MarginaleMajor Surface Protein 1A and 1B Inhibit Infectivity for Cultured Tick Cells, 2002bVeterinary Parasitology111:247-260.
de la Fuente et al., Characterization of the Functional Domain of Major Surface Protein 1A Involved in Adhesion of the RickettsiaAnaplasma Marginaleto Host Cells, 2003Veterinary Microbiology91:265-283.
de la Fuente et al., Evolution and Function of Tandem Repeats in the Major Surface Protein 1A of the Ehrlichial PathogenAnaplasma Marginale, 2001aAn. Health Res. Rev.2:2:163-173.
de la Fuente et al., 2003Expert Rev. Vaccines2/4:583-593.
de la Fuente et al., 2002Vet. Microbiology89:239-251.
Eid et al., Expression of Major Surface Protein 2 Antigenic Variants During AcuteAnaplasma MarginaleRickettsemia, 1996Infect. Immun.64:836-841.
Kocan et al., Immunization of Cattle withAnaplasma MarginaleDerived from Tick Cell Culture, 2001Vet. Parasitol102: 151-161.
Kocan, Development ofAnaplasma Marginale: Coordinated Development of a Rickettsial Organisms and Its Tick Host, 1986Morphology, Physiology and Behavioral Ecology of TicksChichester, Horwood, pp. 472-505.
Kocan, Preliminary Studies on the Effect ofAnaplasma MarginaleAntibodies Ingested byDermacentor AndersoniTicks (Acari: Ixodidae) with Their Bloodmeal on Infections in Salivary Glands, 1996Exp. Acarol. 20:297-311.
Montenegro-James et al., Efficacy of PurifiedAnaplasma MarginaleInitial Bodies as a Vaccine Against Anaplasmosis, 1991Parasitol. Res.77:93-101.
Palmer et al., Strain Composition of the EhrlichiaAnaplasma MarginaleWithin Persistently Infected Cattle, a Mamalian Reservoir for Tick Transmission, 2001J. Clin. Microbiol.39:631-635.
Blouin Edmour F.
de la Fuente Jose de Jesus
Garcia-Garcia Jose Carlos
Kocan Katherine M.
Fellers Snider Blankenship Bailey & Tippens, P.C.
Minnifield Nita
The Board of Regents for Oklahoma State University
LandOfFree
Immunoprotective recombinant antigen from anaplasma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoprotective recombinant antigen from anaplasma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoprotective recombinant antigen from anaplasma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3401001